Blood Cancer Journal Q1 Unclaimed
Nature Publishing Group
United States
Blood Cancer Journal is a journal indexed in SJR in Hematology and Oncology with an H index of 68. It is an CC BY Journal with a Single blind Peer Review review system, and It has a price of 3690 €. The scope of the journal is focused on hematologic malignancies, blood cancer, immunology. It has an SJR impact factor of 3,699 and it has a best quartile of Q1. It is published in English. It has an SJR impact factor of 3,699.
Blood Cancer Journal focuses its scope in these topics and keywords: patients, cell, risk, monoclonal, nk, gammopathy, gammopathiesresponse, goelams, groups, identifies, ...
Type: Journal
Type of Copyright: CC BY
Languages: English
Open Access Policy: Open Access
Type of publications:
Publication frecuency: -
Categories:
Hematology (Q1)
Oncology (Q1)
Price
3690 €
Inmediate OANPD
Embargoed OA- €
Non OAMetrics
3,699
SJR Impact factor68
H Index170
Total Docs (Last Year)423
Total Docs (3 years)5210
Total Refs3047
Total Cites (3 years)268
Citable Docs (3 years)7.69
Cites/Doc (2 years)30.65
Ref/DocOther journals with similar parameters
CA - A Cancer Journal for Clinicians Q1
Journal of Hematology and Oncology Q1
Blood Q1
The Lancet Haematology Q1
Leukemia Q1
Compare this journals
Comments